0
Article Tier 2 Sign in to save

Scalable Urine Test for Microplastics and Nanoplastics: Development Progress, Regulatory Strategy, and Planned Observational Study

AI summary Read the abstract

Researchers described progress toward a smartphone-compatible urine assay for microplastic and nanoplastic detection designed for repeated home use, outlining its regulatory strategy, prototype development stages, and a planned observational study to validate real-world exposure monitoring in human populations.

Microplastics and nanoplastics (MPs/NPs) have been increasingly reported in human biological systems, yet scalable routine monitoring tools remain limited. Current approaches rely largely on specialized laboratory workflows that are expensive, slow, contamination-sensitive, and not designed for repeat home use. This paper outlines progress toward a smartphone-based urine assay intended for environmental exposure awareness and longitudinal wellness monitoring. The program includes prototype development, regulatory planning through FDA Pre-Submission engagement (Q-Sub submitted), and a planned observational study beginning in late summer or fall 2026. The broader goal is to make routine exposure measurement more accessible, practical, and scalable.

More Papers Like This

Article Tier 2

Scalable Urine Test for Microplastics and Nanoplastics: Development Progress, Regulatory Strategy, and Planned Observational Study

AI summary Read the abstract

Researchers describe progress toward a smartphone-based urine assay for measuring personal microplastic and nanoplastic exposure, reporting prototype development, an FDA pre-submission regulatory engagement, and a planned observational study in 2026 aimed at making longitudinal exposure monitoring scalable and accessible outside specialized laboratories.

Article Tier 2

Scalable Urine Test for Microplastics and Nanoplastics: Development Progress, Regulatory Strategy, and Planned Observational Study

AI summary Read the abstract

Researchers are developing a smartphone-based urine assay for routine microplastic and nanoplastic exposure monitoring, with FDA Pre-Submission engagement underway and an observational study planned for late 2026, aiming to make home-based longitudinal exposure measurement practical and scalable.

Article Tier 2

Toward a Harmonized Framework for Standardization for Scalable and Reproducible Measurement of Microplastic and Nanoplastic Monitoring in Human Urine

AI summary Read the abstract

Researchers propose a technology-agnostic standardization framework for measuring microplastics and nanoplastics in human urine, defining shared principles around reproducibility, contamination control, and scalability to enable population-level longitudinal monitoring beyond the small, cross-sectional cohorts that currently dominate the literature.

Article Tier 2

Toward a Harmonized Framework for Standardization for Scalable and Reproducible Measurement of Microplastic and Nanoplastic Monitoring in Human Urine

AI summary Read the abstract

Researchers propose a technology-agnostic standardization framework for measuring microplastics and nanoplastics in human urine, defining shared principles around reproducibility, contamination control, and scalability to enable population-level longitudinal monitoring beyond the small, cross-sectional cohorts that currently dominate the literature.

Article Tier 2

Urine Color Differences Do Not Interfere with Optical Analysis in the EcoExposureTM Microplastic and Nanoplastic Assay

AI summary Read the abstract

Researchers observed that natural variation in urine color did not prevent reliable optical pattern detection in the EcoExposure microplastic assay, supporting the feasibility of smartphone-based urine testing for microplastic and nanoplastic exposure in decentralized or field settings.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper